We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hologic (HOLX) Partners With Gallup on Women's Health Index
Read MoreHide Full Article
Hologic, Inc. (HOLX - Free Report) recently entered into a multi-year initiative with Gallup, Inc. to develop Hologic Global Women’s Health Index. Notably, Hologic conducted Global Women’s Health Index survey through Gallup’s World Poll in more than 115 countries.
Hologic’s Global Women’s Health Index will generate distinctive insight on reproductive health, domestic violence, preventive care, access to care and early detection of disease.
For investors’ note, Gallup World Poll survey connects with more than 90% of the world's adult population through annual, nationally representative surveys with comparable metrics across countries.
With the recent development, Hologic aims to expand access in women’s healthcare market.
More in the News
Hologic started working with Gallup in 2019 to fortify the grounds of its continuous efforts to support women’s health around the world. The collaboration is helping Hologic bridge the gap of a critical need for a data-driven approach to women’s health.
Hologic in partnership with Gallup highlighted eight essential questions to provide meaningful data on women’s health. Moreover, to ensure complete assessment of women’s health, the index will be featured by country-level reports as well as rankings indicating how countries manage on key indicators of women’s health.
Global Women’s Health Index and Its Progress
As part of a multi-year initiative, Hologic conducted Global Women’s Health survey through Gallup World Poll to track critical aspects of women’s health and safety globally. Notably, the survey included individual responses from more than 120,000 people across 116 countries and in 40 languages.
Per management, the Hologic Global Women’s Health Index will bring awareness to the most vital health issues women are facing globally by offering unique regional insights.
Recent Developments in Women’s Health
Hologic has been making impressive progress in its Breast Health arm over the past few months. The company launched the SuperSonic MACH 20 ultrasound system in January. The same month, Hologic announced the availability of 3D ultrasound imaging on the SuperSonic MACH 30 and 20 ultrasound systems in Europe.
Also in January, Hologic announced plans to acquire Biotheranostics, a privately-held commercial-stage company providing molecular diagnostic tests for breast and metastatic cancer.
Within GYN Surgical, Hologic launched its latest CE-marked Fluent fluid management system in Europe in January 2021. The system is equipped with an integrated MyoSure controller, which can maximize the MyoSure system’s performance with Fluent’s fluid and vacuum systems.
The company, in November 2020, launched the Omni Suite (a comprehensive surgical offering designed to optimize diagnostic and operative hysteroscopy) and acquired Acessa Health (in the field of minimally-invasive treatment for fibroids).
Industry Prospects
Per a report by Grand View Research, the global women’s health market size was worth $32 billion in 2019 and is projected to see a CAGR of 4.9% by 2027. An increase in the population of women aged over 60, a rise in the adoption of unhealthy lifestyle habits and the introduction of novel medicines for women are driving the market.
Price Performance
Shares of the company have gained 61% in a year’s time compared with the industry’s growth of 26.8%.
ConforMIS has a projected long-term earnings growth rate of 42%.
IDEXX Laboratories has a projected long-term earnings growth rate of 16%.
Bioanalytical Systems has a projected long-term earnings growth rate of 15%.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
Image: Shutterstock
Hologic (HOLX) Partners With Gallup on Women's Health Index
Hologic, Inc. (HOLX - Free Report) recently entered into a multi-year initiative with Gallup, Inc. to develop Hologic Global Women’s Health Index. Notably, Hologic conducted Global Women’s Health Index survey through Gallup’s World Poll in more than 115 countries.
Hologic’s Global Women’s Health Index will generate distinctive insight on reproductive health, domestic violence, preventive care, access to care and early detection of disease.
For investors’ note, Gallup World Poll survey connects with more than 90% of the world's adult population through annual, nationally representative surveys with comparable metrics across countries.
With the recent development, Hologic aims to expand access in women’s healthcare market.
More in the News
Hologic started working with Gallup in 2019 to fortify the grounds of its continuous efforts to support women’s health around the world. The collaboration is helping Hologic bridge the gap of a critical need for a data-driven approach to women’s health.
Hologic in partnership with Gallup highlighted eight essential questions to provide meaningful data on women’s health. Moreover, to ensure complete assessment of women’s health, the index will be featured by country-level reports as well as rankings indicating how countries manage on key indicators of women’s health.
Global Women’s Health Index and Its Progress
As part of a multi-year initiative, Hologic conducted Global Women’s Health survey through Gallup World Poll to track critical aspects of women’s health and safety globally. Notably, the survey included individual responses from more than 120,000 people across 116 countries and in 40 languages.
Per management, the Hologic Global Women’s Health Index will bring awareness to the most vital health issues women are facing globally by offering unique regional insights.
Recent Developments in Women’s Health
Hologic has been making impressive progress in its Breast Health arm over the past few months. The company launched the SuperSonic MACH 20 ultrasound system in January. The same month, Hologic announced the availability of 3D ultrasound imaging on the SuperSonic MACH 30 and 20 ultrasound systems in Europe.
Also in January, Hologic announced plans to acquire Biotheranostics, a privately-held commercial-stage company providing molecular diagnostic tests for breast and metastatic cancer.
Within GYN Surgical, Hologic launched its latest CE-marked Fluent fluid management system in Europe in January 2021. The system is equipped with an integrated MyoSure controller, which can maximize the MyoSure system’s performance with Fluent’s fluid and vacuum systems.
The company, in November 2020, launched the Omni Suite (a comprehensive surgical offering designed to optimize diagnostic and operative hysteroscopy) and acquired Acessa Health (in the field of minimally-invasive treatment for fibroids).
Industry Prospects
Per a report by Grand View Research, the global women’s health market size was worth $32 billion in 2019 and is projected to see a CAGR of 4.9% by 2027. An increase in the population of women aged over 60, a rise in the adoption of unhealthy lifestyle habits and the introduction of novel medicines for women are driving the market.
Price Performance
Shares of the company have gained 61% in a year’s time compared with the industry’s growth of 26.8%.
Zacks Rank and Other Key Picks
Currently, Hologic carries a Zacks Rank #2 (Buy).
A few same-ranked stocks from the broader medical space are ConforMIS, Inc. , IDEXX Laboratories, Inc. (IDXX - Free Report) and Bioanalytical Systems, Inc. . You can see the complete list of Zacks #1 Rank (Strong Buy) stocks here.
ConforMIS has a projected long-term earnings growth rate of 42%.
IDEXX Laboratories has a projected long-term earnings growth rate of 16%.
Bioanalytical Systems has a projected long-term earnings growth rate of 15%.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>